President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk's Wegovy and Eli ...

The proposal would have given millions more Americans access to those drugs, but would have cost the government billions. Many health plans, including Medicare, don't currently cover weight loss ...